LONDON, Nov.9, 2017 /PRNewswire/ -- Download the full report: https://www.reportbuyer.com/product/4985959
The Report covers the therapeutics
This report provides the diagnosed cases of Parkinson's disease (PD). Changes in diagnostic practice over time and increase in aging population will slowly increase the diagnosed cases of PD. According to DelveInsight, the prevalent population of Parkinson's disease (PD) is expected to reach up to XXX cases by the end of 2025 at a CAGR of 4.69% from 2015-2025. High prevalent cases were observed in United States as compared to EU5 and Japan.
The market size is driven by several approved drugs that are being used for the treatment of Parkinson's disease such as Neupro (UCB Group of Companies), Xadago (Newron Pharmaceuticals S.p.A.) and Exelon (Novartis).
United States contributes the major share of Parkinson's disease (PD) market as compared to EU5 countries and Japan. The therapeutic market of PD in 7MM is expected to reach USD 4.91 Billion in 2025 at the CAGR of XX% from 2015-2025.
Key Coverage and Benefits:
Download the full report: https://www.reportbuyer.com/product/4985959
About Reportbuyer Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers https://www.reportbuyer.com
For more information: Sarah Smith Research Advisor at Reportbuyer.com Email: firstname.lastname@example.org Tel: +44 208 816 85 48 Website: www.reportbuyer.com
View original content:http://www.prnewswire.com/news-releases/parkinsons-disease---market-insights-epidemiology-and-market-forecast--2025-300553658.html
Subscribe to our Free Newsletters!
Palliative care is a specialized multifaceted care for patients with chronic or terminal illness to ...
Our kitchen and food has the best medicinal properties to fight stress. These are the top 10 foods ...
Unripe green papaya fruit is a rich source of important nutrients including vitamins, proteins, & ...View All